Your browser doesn't support javascript.
loading
Comparing Iridium-192 with Cobalt-60 sources in high-dose-rate brachytherapy boost for localized prostate cancer.
Tamihardja, Jörg; Weick, Stefan; Lutyj, Paul; Zimmermann, Marcus; Bratengeier, Klaus; Flentje, Michael; Polat, Bülent.
Affiliation
  • Tamihardja J; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
  • Weick S; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
  • Lutyj P; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
  • Zimmermann M; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
  • Bratengeier K; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
  • Flentje M; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
  • Polat B; Department of Radiation Oncology, University of Wuerzburg, Wuerzburg, Germany.
Acta Oncol ; 61(6): 714-719, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35485446
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Brachytherapy Limits: Humans / Male Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2022 Document type: Article Affiliation country: Germany